Search Results - "Noordhuis, Maartje"

Refine Results
  1. 1
  2. 2

    OGDHL is a modifier of AKT-dependent signaling and NF-κB function by Sen, Tanusree, Sen, Nilkantha, Noordhuis, Maartje G, Ravi, Rajani, Wu, T-C, Ha, Patrick K, Sidransky, David, Hoque, Mohammad Obaidul

    Published in PloS one (12-11-2012)
    “…Oxoglutarate dehydrogenase (OGDH) is the first and rate-limiting component of the multi-enzyme OGDH complex (OGDHC) whose malfunction is associated with…”
    Get full text
    Journal Article
  3. 3

    High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas by Inokawa, Yoshikuni, Hayashi, Masamichi, Begum, Shahnaz, Noordhuis, Maartje G, Sidransky, Daivd, Califano, Joseph, Koch, Wayne, Brait, Mariana, Westra, William H, Hoque, Mohammad O

    Published in BMC cancer (07-11-2022)
    “…Background HPV-positive oropharyngeal squamous cell carcinomas (OPSCCs) are sensitive to chemo-radiation therapy and have favorable survival outcomes compared…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    High pATM is Associated With Poor Local Control in Supraglottic Cancer Treated With Radiotherapy by Bruine de Bruin, Leonie, Schuuring, Ed, Bock, Geertruida H., Slagter‐Menkema, Lorian, Mastik, Mirjam F., Noordhuis, Maartje G., Langendijk, Johannes A., Kluin, Philip M., Laan, Bernard F.A.M.

    Published in The Laryngoscope (01-08-2020)
    “…Objectives Most early stage laryngeal squamous cell carcinomas (LSCC) are treated with radiotherapy. Discovery of new biomarkers are needed to improve…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Biological tumor markers associated with local control after primary radiotherapy in laryngeal cancer: A systematic review by Noordhuis, Maartje G., Kop, Emiel A., van der Vegt, Bert, Langendijk, Johannes A., Laan, Bernard F. A. M., Schuuring, Ed, Bock, Geertruida H.

    Published in Clinical otolaryngology (01-07-2020)
    “…Background The choice of treatment in laryngeal cancer is mainly based on tumor stage, post‐treatment morbidity and quality of life. Biological tumor markers…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20